论文期刊

取消

高级检索

检索历史清除

首页> Retina (Philadelphia, Pa.)> ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN DIABETIC MACULAR EDEMA: RESULTS FROM A LARGE SINGLE-CENTER COHORT WITH BEVACIZUMAB AS FIRST-LINE THERAPY.

ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN DIABETIC MACULAR EDEMA: RESULTS FROM A LARGE SINGLE-CENTER COHORT WITH BEVACIZUMAB AS FIRST-LINE THERAPY.

导出 LinkOut

翻译打印收藏纠错

作者： Dinah,Zur ^[1] ; Keren,Hod ^[2] ; Omer,Trivizki ^[3] ; David,Rabinovitch ^[4] ; Shulamit,Schwartz ^[1] ; Shiri,Shulman ^[5]

作者单位： Ophthalmology Division, Tel Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[1] Department of Academy and Research, Assuta Medical Centers, affiliated to Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva. ^[2] Ophthalmology Division, Tel Aviv Sourasky Medical Center, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.;Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA. ^[3] Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and. ^[4] Ophthalmology Institute, Assuta Medical Centers, affiliated to Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva. ^[5]

主题词人类(Humans);黄斑水肿(Macular Edema);血管生成抑制剂(Angiogenesis Inhibitors);回顾性研究(Retrospective Studies);糖尿病视网膜病变(Diabetic Retinopathy);中年人(Middle Aged);男(雄)性(Male);视敏度(Visual Acuity);女(雌)性(Female);玻璃体内注射(Intravitreal Injections);血管内皮生长因子A(Vascular Endothelial Growth Factor A);老年人(Aged);随访研究(Follow-Up Studies);体层摄影术, 光学相干(Tomography, Optical Coherence);治疗结果(Treatment Outcome)

DOI 10.1097/IAE.0000000000004096

PMID 38471038

发布时间 2024-10-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Retina (Philadelphia, Pa.)

Retina (Philadelphia, Pa.)

2024年44卷8期

1305-1313页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷